loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2004_238___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    HTL Biotechnology

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HTL Javené FR (1)

    filter

    01 Sodium hyaluronate, Intrinsic viscosity 0.2 to 2.4 m3/kg; by fermentation; for parenteral administration and for intra-ocular and intra-articular use (1)

    filter

    01 France (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    HTL Javené FR

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothHTL Biotechnology is the world leader in the responsible development and production of pharmaceutical-grade biopolymers.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Sodium hyaluronate, Intrinsic viscosity 0.2 to 2.4 m3/k...

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF Russia
    R1-CEP 2004-238 - Rev 05
    Valid
    Chemical
    2022-07-18
    1472
    HTL Biotechnology Biopolymer

    AMWC Asia-TDAC

    Exhibiting

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-238 - Rev 05 of Htl Javené Fr

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2004-238 - Rev 05 of Htl Javené Fr 1

    20

    Htl Javené Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for HTL Biotechnology is the world leader in the responsible development and production of pharmaceutical-grade biopolymers.

    One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity 0.2 to 2.4 m3/kg; by fermentation; for parenteral administration and for intra-ocular and intra-articular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-238 - Rev 05

    This Chemical Type CEP, issued on July 18, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1472 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY